A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

November 30, 2018

Conditions
MelanomaLung CancerRenal Cell Carcinoma
Interventions
BIOLOGICAL

BCD-100

Anti-PD1 monoclonal antibody

Trial Locations (4)

197758

N.N.Petrov Oncology Research Center, Saint Petersburg

Unknown

"Russian Cancer Research Center named after N.N. Blokhin of the Ministry of Health of the Russian Federation", Moscow

LLC BioEk, Saint Petersburg

"State budgetary health care institution St. Petersburg Clinical Scientific and Practical Center of Specialized Medical Assistance (Oncological)", Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biocad

INDUSTRY